August 9th, 2022 at 10am PT  

With Congress recently proposing the most comprehensive decriminalization bill to date, we are closer than ever to seeing the federal legalization of recreational Cannabis.

Even though cannabis has been stealing the show the last decade or so, there is another emerging industry waiting patiently to see what becomes of this bill in the Senate: psychedelics.

Researchers have found many medicinal benefits in psychedelics for the treatment of PTSD and depression, but, much like Cannabis, their use is often looked at as a legislative issue and not a matter of health. Proponents of psychedelics hope that the recent positive public sentiment towards Cannabis will carry over to their industry.

Thus far, we can only assume that businesses that specialize in psychedelics would be regulated similarly to those in the cannabis industry upon legalization, but that begs more questions than answers for those who will be serving these companies.

On Tuesday, August 9th at 10 AM PT we will be joined by special guest speaker Amanda Reiman, who will be giving us an introduction into the world of psychedelics and the businesses that surround them.

Amanda will be covering:
  • Current laws around cannabis and psychedelics
  • How consumption behaviors will dictate the differences in the cannabis and psychedelics market
  • Implications for the medicalization of psychedelics
  • Deep dive into Cannabis and other psychedelic tourism as an emerging trend
  • Potential future models and their risks and benefits
  • The role of accounting in the expansion of legalization of other Schedule I drugs

If you're a member, to register for this event or catch the replay, login to your member area.

Not a NACAT PROs Member?

Join today for a 30-day free trial to access this event, watch past events, get CPE and more!


Amanda Reiman

founder of Personal Plants


Amanda Reiman, the founder of Personal Plants, is an activist, professor, and researcher with twenty years of experience studying the relationship between people and plants. Her experience as the Manager of Marijuana Law and Policy for the Drug Policy Alliance enabled her to make real change in how the world treats medicinal plants like cannabis. Amanda was also the first chairwoman of the Medical Cannabis Commission for the City of Berkeley and taught classes on drug use and policy at UC Berkeley for over a decade. She strives to empower, enlighten and guide others to take their healing and creativity journey into their own hands by spreading knowledge and access to information and inspiration.